Shields to head Artomick
William Shields, named CEO of Artomick, a medication management and technology company.
Artomick International has named William Shields, R.Ph., as its new CEO. Artomick develops medication management and healthcare technology solutions for acute and long-term care markets. J.M. Romick, the founder and former CEO, is retiring from the company. Most recently Shields served as the senior VP strategic initiatives at AmerisourceBergen.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
